- Biomerica press release ( NASDAQ: BMRA ): FQ2 net loss was $1.6M for the three months ended November 30, 2022 compared to a net loss of $1.1M for the three months ended November 30, 2021.
- Gross margin during the quarter ended November 30, 2022 increased to 24% as compared to a gross margin of 17% in the second fiscal quarter 2022.
- Cash and cash equivalents at the end of the fiscal second quarter was $5.1M, a net decrease of $0.8M during the first six-months of fiscal 2023.
- Revenue of $1.5M (-67.4% Y/Y).
For further details see:
Biomerica reports FQ2 results